Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Philip Poorvu's Talks
Philip Poorvu
Dana-Farber Cancer Institute
DESTINY-Breast04 eligibility
October 20, 2026
Philip Poorvu
Dana-Farber Cancer Institute
00:00
--:--
DESTINY-Breast04: trial design and primary endpoint
October 20, 2026
Share
DESTINY-Breast04: trial design and primary endpoint
https://www.medspoke.co/channel_playlist?object_id=879&tap_id=15979
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Philip Poorvu
Dana-Farber Cancer Institute
DAISY: Early clues to T-DXd resistance
October 20, 2026
Why are you reporting this TALK?
